EXAS vs KD · rev $2.76B vs P/E 14, rev $15.06B
EXACT Sciences Corporation (EXAS) versus Kyndryl Holdings Inc (KD) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Kyndryl Holdings Inc (KD) is a information technology services company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported KD revenue for 2025-03-31 was $15.06B. Net income was $252.0M. Revenue was down 6.2% from 2024-03-31 to 2025-03-31. KD currently screens at market cap $2.69B and trailing P/E 14.4.
EXAS currently screens at market cap $20.03B. KD currently screens at market cap $2.69B and trailing P/E 14.4.
Not investment advice. Open the EXAS and KD stock pages for the full models.
Not investment advice.